Shanghai Canming Medical Technology

Shanghai Canming Medical Technology is a China-based healthcare services company focused on clinical trial data management, biostatistics, and related technical support for drug developers, manufacturers, and CROs. The company operates as a specialty CRO service provider rather than a therapeutic-product developer, with capabilities spanning database build, data collection and storage, statistical analysis, quality control, randomization and blinding, and EDC system support. It has supported studies across phases I-IV, including vaccines, medical devices, reagents, and bioequivalence research. The company is a wholly owned subsidiary of Beijing Haijinge Pharmaceutical Technology and has been recognized as a high-tech enterprise and specialized SME in Shanghai. Its business appears to be commercially active, with 2024 revenue reported in the low tens of millions of RMB and a small employee base.